Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-3925

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-3925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Oxcarbazepine 600mg 70518 3925 01)

Label for Oxcarbazepine 600 mg film-coated tablet, quantity 1 tablet. The label includes the NDC number 70518-3925-01, manufacturer Camber Pharma, Inc., and repackager RemedyRepack Inc. Directions reference the package insert. Storage temperature guidelines from 20-25°C with permitted excursions are noted. The label is marked RX Only.*

FDA Label Image

Remedy_label (Remedy Label)

Oxcarbazepine 600 mg film-coated tablets label showing the quantity of 100 tablets. The label indicates prescription use only, with NDC 70518-3925-00, repackaged by RemedyRepack Inc. It includes manufacturer information for Camber Pharma, Inc., and storage instructions. A barcode and a QR code are present on the label.*

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

A Kaplan-Meier survival curve chart displaying exit rates over time from Day 2 to Day 11. The graph compares two treatment groups: Oxcarbazepine and Placebo, with the exit rate increasing more rapidly for the Placebo group. The chart includes a log-rank test p-value of 0.0001, indicating statistical comparison between the groups.*

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

A Kaplan-Meier curve showing seizure rate over days from first dose to first seizure, comparing Oxcarbazepine and placebo treatment groups. The x-axis represents days, while the y-axis shows seizure rate. The graph includes a log-rank test p-value of 0.046.*

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

A Kaplan-Meier curve showing exit rates over time (days) for two treatment groups labeled HIGH and LOW. The graph plots exit rate on the y-axis from 0 to 1.0 against time on the x-axis up to 130 days. The HIGH group is represented by a solid line, and the LOW group by a dashed line. A statistical note indicates a log-rank test with a p-value of 0.0001.*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

Kaplan-Meier survival curve showing exit rate over time in days for two treatment groups labeled HIGH (solid line) and LOW (dashed line). The y-axis represents exit rate from 0 to 1, and the x-axis shows time to exit in days from 0 to 130. A log-rank test p-value of 0.0001 is displayed, indicating statistical comparison between the groups.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

Chemical structure of oxcarbazepine, showing its molecular framework with two benzene rings and amide groups as characteristic features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.